Telitacicept for the Treatment of Refractory RA
Clinical trial NCT07008196 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07008196
- Sponsor
- Chinese SLE Treatment And Research Group
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-10
- Primary completion
- 2025-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.